NIO Inc. (NIO) Q2 2026 (CNY): EPS -0.29 (exp. -0.45), 32.1bln Revenue (exp. 33.40bln), Vehicle Sales 29.058bln (prev. 16.136bln Y/Y), Gross Profit 5.907bln (prev. 1.898bln Y/Y)
Newsquawk Staff ·
- Operating Loss -347.2mln (prev. -4.909bln Y/Y)
- Adj. Operating Profit 206.9mln (prev. -4.041bln Y/Y)
- Net Loss -528.0mln (prev. -4.995bln Y/Y)
- Adj. Net Profit 26.1mln (prev. -4.127bln Y/Y)
- Gross margin 18.4% (prev. 10.0% Y/Y, +840bps)
- Vehicle margin 18.5% (prev. 10.3% Y/Y, +820bps)
- Deliveries 107,658 (prev. 72,056 Y/Y, +49.4%)
- Q3 guidance deliveries 108,000-111,000 and revenue 33.285-34.051bln (exp. 36.33bln).
What it means
The print is the familiar Chinese EV mix: an EPS beat on the headline loss line against a revenue miss, with the real information in the margin line rather than the per-share figure. Gross and vehicle margins up several hundred basis points year on year is the part of the release that historically drives the re-rating debate for this peer set, since the sector's equity story has long turned on whether price competition permits margin repair; a beat built on volume growth with margins expanding is read differently from one built on discounting, and the delivery growth alongside margin gains here is the former configuration. The crossover into adjusted operating and net profitability, after a string of deeply negative prints, is the kind of inflection that has previously split the tape between those treating it as structural and those treating it as mix and cost timing, and the gap between adjusted and unadjusted figures is where that argument concentrates. Guidance is the counterweight: the Q3 revenue range sitting below consensus is the established mechanism by which a strong quarter gets faded in this name, and the delivery guide implying only modest sequential growth frames it. Worth watching are the call commentary on pricing and new model cadence, the battery-swap and sub-brand contribution to the margin line, and whether peers' prints confirm the sector-wide margin recovery or mark this as idiosyncratic.
- US FDA has approved Novo's (NOVOB DC) once-weekly insulin treatment for paediatric patients with type 2 diabetes mellitus
- Meta's (META) Muse AI to counter China models with subscribers, not ads, Nikkei reports
- Toyota (TM) to recall 68k late model 2022-2024 Lexus NX vehicles in the US due to a display flaw
- Genmab (GMAB) Phase 3 Rina data in ovarian cancer shows PFS and OS endpoints were met
- TikTok’s US entity is reportedly exploring deals to secure multiple gigawatts of computing capacity over the coming years, according to CNBC
Related headlines
- Infosys (INFY) Q2 2026 (INR): Net profit 78.2bln (exp. 79.3bln ), revenue 492.4bln (exp. 491.3bln); lowers FY27 revenue view14 hours ago
- Anthropic and Hg have agreed to form an independent consultancy Co. targeting corporate clients, FT reports citing sources16 hours ago
- Week in Focus 26-30th October 2026: FOMC, BoC, RBNZ, ECB, BoJ Policy Decisions, US PCE5 hours ago
- US Midterm Preview: Democrats Favoured to Flip the House, Senate Too Close to Call5 hours ago
- Newsquawk Daily Economic Release - 26th October 202611 hours ago
- Newsquawk Weekly Economic Release 26th - 30th October 2026 11 hours ago
- Newsquawk European Market Wrap - 23rd October 202611 hours ago
- US EQUITY OPEN: Breadth poor at the open: Energy leads gains on oil rally, Tech sees slight bounce11 hours ago
- US S&P Global Manufacturing PMI Flash (Oct) 56.0 vs. Exp. 55.5 (Prev. 55.9)11 hours ago
- US S&P Global Services PMI Flash (Oct) 57.9 vs. Exp. 58 (Prev. 58.8)11 hours ago
- US S&P Global Composite PMI Flash (Oct) 57.6 (Prev. 58.4)11 hours ago
- Belgian Business Confidence (Oct) -9.8 vs. Exp. -11.8 (Prev. -12.1)12 hours ago
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation12 hours ago
- Canadian Retail Sales (Aug YY) 5.4% (Prev. 5.1%)13 hours ago
- Canadian Retail Sales Prel (Sep MM) 0.7% (Prev. 1.3%)13 hours ago